<DOC>
	<DOCNO>NCT02758301</DOCNO>
	<brief_summary>The purpose LINQ™ HF study characterize Reveal LINQ™ derive data patient heart failure assess relationship change LINQ™ derive data physiologic parameter subsequent acute decompensated heart failure ( ADHF ) event .</brief_summary>
	<brief_title>Reveal LINQ™ Heart Failure</brief_title>
	<detailed_description>The study prospective , non-randomized , multi-center , observational , pre-market clinical study . The study expect conducted 30 center United States . Up 300 subject enrol achieve approximately 40 heart failure event ( two per subject contribute cumulative total ) . Study subject follow 3 year post-insertion official study closure define Medtronic and/or regulatory requirement satisfy per Clinical Investigation Plan and/or decision Medtronic regulatory authority , whichever occur first . The expected study duration approximately 4 year represent 1.5 year enrollments 2.5 year follow-up . The LINQ™ HF study Non-Significant Risk Investigational Device Exemption ( IDE ) study . The study utilizing Reveal LINQ™ device investigational LINQ™ HF RAMware download .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patient 18 year age old Patient ( patient 's legally authorize representative ) willing able provide write informed consent Patient willing able comply protocol , include followup visit Carelink transmission . Patient NYHA Class III , per recent assessment time within 30 day prior enrollment Patient HF event ( HF event define meet one follow three criterion ) : 1 . Admission primary diagnosis HF within last 6 month , OR 2 . Intravenous HF therapy ( e.g . IV diuretics/vasodilators ) ultrafiltration one follow setting within last 6 month : Admission secondary/tertiary diagnosis HF Emergency Department Ambulance Observation Unit Urgent Care HF/Cardiology Clinic Patient 's Home , OR 3 . Patient follow BNP/NTproBNP within last 3 month : If EF ≥ 50 % , BNP &gt; 200 pg/ml NTproBNP &gt; 400 pg/ml OR If EF &lt; 50 % , BNP &gt; 400 pg/ml NTproBNP &gt; 800 pg/ml Patient pregnant ( female childbearing potential must negative pregnancy test within 1 week enrollment ) Patient enrol another study could confound result study , without document preapproval Medtronic study manager Patient severe valvular heart disease define hemodynamically significant valve stenosis and/or prosthetic heart valve Patient exist IPG , ICD , CRTD CRTP device Patient severe renal impairment ( eGFR &lt; 25mL/min )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>